Table 2.
Clinical and laboratory parameters in patients with RA before and after treatment with rituximab
| Parameter | Before treatment | After treatment | P value |
|---|---|---|---|
| DAS-28 | 6.28 ± 0.24 | 3.84 ± 0.30 | 0.001 |
| HAQ | 2.89 ± 0.83 | 1.52 ± 0.61 | 0.05 |
| Mean serum RF | 721.84 ± 51.5 | 93.32 ± 30.3 | 0.001 |
| Mean ESR (mm/hr) | 35.5 ± 5.21 | 18 ± 6.35 | 0.001 |
| Mean serum CRP (mg/dL) | 27.21 ± 3.76 | 11.54 ± 1.92 | 0.001 |
| Mean serum anti-CCP (U/mL) | 563.34 ± 93.64 | 350.75 ± 113.25 | 0.001 |
Abbreviations: RA, rheumatoid arthritis; DAS, disease activity score; HAQ, health assessment questionnaire; RF, rheumatoid factor; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; anti-CCP, anti-cyclic citrullinated peptide.